Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics-Reference-Cited by-同舟云学术

Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics

Published:1999-10 Issue:4 Volume:60 Page:201-208
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Rahimy Mohamad H.,Cromie Matthew A.,Hopkins Nancy K.,Tong Donald M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference15 articles.

1. United Nations Population Fund. Contraceptive requirements and demand for contraceptive commodities in developing countries in the 1990s. February 1991.

2. Preventing Pregnancy, Protecting Health;Harlap,1991

3. A review of ‘once-a-month’ combined injectable contraceptives;Newton;J Obstet Gynaecol,1994

4. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations;Aedo;Contraception,1985

5. A preliminary pharmacological trial of the monthly injectable contraceptive Cyclo-Provera;Fotherby;Contraception,1982

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of a single dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users: A randomized double-blind placebo-controlled trial;Contraception;2024-03

2. Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans—a Review;The AAPS Journal;2022-12-01

3. Variability and quantification of serum medroxyprogesterone acetate levels;Steroids;2022-11

4. Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception;Pharmacology & Therapeutics;2021-06

5. An integrated approach to the management of patients with endometrial hyperplasia and metabolic syndrome;Gynecology;2021-03-21